38228889|t|Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
38228889|a|Early and progressive dysfunctions of the dopaminergic system from the Ventral Tegmental Area (VTA) have been described in Alzheimer's Disease (AD). During the long pre-symptomatic phase, alterations in the function of Parvalbumin interneurons (PV-INs) are also observed, resulting in cortical hyperexcitability represented by subclinical epilepsy and aberrant gamma-oscillations. However, it is unknown whether the dopaminergic deficits contribute to brain hyperexcitability in AD. Here, using the Tg2576 mouse model of AD, we prove that reduced hippocampal dopaminergic innervation, due to VTA dopamine neuron degeneration, impairs PV-IN firing and gamma-waves, weakens the inhibition of pyramidal neurons and induces hippocampal hyperexcitability via lower D2-receptor-mediated activation of the CREB-pathway. These alterations coincide with reduced PV-IN numbers and Perineuronal Net density. Importantly, L-DOPA and the selective D2-receptor agonist quinpirole rescue p-CREB levels and improve the PV-IN-mediated inhibition, thus reducing hyperexcitability. Moreover, similarly to quinpirole, sumanirole - another D2-receptor agonist and a known anticonvulsant - not only increases p-CREB levels in PV-INs but also restores gamma-oscillations in Tg2576 mice. Conversely, blocking the dopaminergic transmission with sulpiride (a D2-like receptor antagonist) in WT mice reduces p-CREB levels in PV-INs, mimicking what occurs in Tg2576. Overall, these findings support the hypothesis that the VTA dopaminergic system integrity plays a key role in hippocampal PV-IN function and survival, disclosing a relevant contribution of the reduced dopaminergic tone to aberrant gamma-waves, hippocampal hyperexcitability and epileptiform activity in early AD.
38228889	0	28	Dopamine neuron degeneration	Chemical	-
38228889	78	95	hyperexcitability	Disease	
38228889	112	131	Alzheimer's Disease	Disease	MESH:D000544
38228889	256	275	Alzheimer's Disease	Disease	MESH:D000544
38228889	277	279	AD	Disease	MESH:D000544
38228889	352	363	Parvalbumin	Gene	19293
38228889	427	444	hyperexcitability	Disease	
38228889	472	480	epilepsy	Disease	MESH:D004827
38228889	591	608	hyperexcitability	Disease	
38228889	612	614	AD	Disease	MESH:D000544
38228889	639	644	mouse	Species	10090
38228889	654	656	AD	Disease	MESH:D000544
38228889	729	757	dopamine neuron degeneration	Chemical	-
38228889	865	882	hyperexcitability	Disease	
38228889	893	904	D2-receptor	Gene	13489
38228889	932	936	CREB	Gene	12912
38228889	1043	1049	L-DOPA	Chemical	MESH:D007980
38228889	1068	1079	D2-receptor	Gene	13489
38228889	1088	1098	quinpirole	Chemical	MESH:D019257
38228889	1108	1112	CREB	Gene	12912
38228889	1177	1194	hyperexcitability	Disease	
38228889	1219	1229	quinpirole	Chemical	MESH:D019257
38228889	1231	1241	sumanirole	Chemical	MESH:C108539
38228889	1252	1263	D2-receptor	Gene	13489
38228889	1322	1326	CREB	Gene	12912
38228889	1391	1395	mice	Species	10090
38228889	1453	1462	sulpiride	Chemical	MESH:D013469
38228889	1501	1505	mice	Species	10090
38228889	1516	1520	CREB	Gene	12912
38228889	1828	1845	hyperexcitability	Disease	
38228889	1850	1871	epileptiform activity	Disease	MESH:D014277
38228889	1881	1883	AD	Disease	MESH:D000544
38228889	Positive_Correlation	MESH:D019257	13489
38228889	Negative_Correlation	MESH:D013469	12912
38228889	Positive_Correlation	12912	13489
38228889	Positive_Correlation	MESH:D019257	12912
38228889	Positive_Correlation	MESH:C108539	13489
38228889	Positive_Correlation	MESH:D007980	12912
38228889	Positive_Correlation	MESH:C108539	12912

